Misonix, Inc. (NASDAQ:MSON) Director Patrick A. Mcbrayer acquired 1,000 shares of the company’s stock in a transaction dated Monday, February 12th. The stock was acquired at an average cost of $10.54 per share, for a total transaction of $10,540.00. Following the completion of the acquisition, the director now directly owns 1,100 shares in the company, valued at $11,594. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Misonix, Inc. (MSON) traded up $0.30 during mid-day trading on Monday, hitting $10.40. 15,800 shares of the stock traded hands, compared to its average volume of 9,134. Misonix, Inc. has a fifty-two week low of $7.05 and a fifty-two week high of $12.00.
Hedge funds have recently added to or reduced their stakes in the company. Keybank National Association OH purchased a new stake in shares of Misonix in the 4th quarter valued at $109,000. Vanguard Group Inc. boosted its holdings in shares of Misonix by 0.9% in the 2nd quarter. Vanguard Group Inc. now owns 106,353 shares of the medical equipment provider’s stock valued at $1,027,000 after acquiring an additional 900 shares during the last quarter. Finally, Northern Trust Corp boosted its holdings in shares of Misonix by 2.5% in the 2nd quarter. Northern Trust Corp now owns 24,378 shares of the medical equipment provider’s stock valued at $233,000 after acquiring an additional 591 shares during the last quarter. 10.34% of the stock is currently owned by institutional investors and hedge funds.
TRADEMARK VIOLATION NOTICE: This story was first posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international trademark and copyright law. The legal version of this story can be accessed at https://www.americanbankingnews.com/2018/02/12/insider-buying-misonix-inc-mson-director-acquires-1000-shares-of-stock.html.
Misonix, Inc designs, manufactures, develops and markets minimally invasive therapeutic ultrasonic medical devices. The Company’s products include BoneScalpel surgical system (BoneScalpel), SonaStar Surgical Aspirator (SonaStar), and SonicOne Wound Cleansing and Debridement System (SonicOne). These devices primarily serve the neurosurgery, orthopedic surgery, plastic surgery, wounds, burn and maxillo-facial clinical specialties.
Receive News & Ratings for Misonix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Misonix and related companies with MarketBeat.com's FREE daily email newsletter.